INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
11/30/2024
Back to search
Official data from USPTO
MEDISON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
11/30/2024
Trademark type
Combined
Nice classes
5, 35
Filing date
11/16/2020
Registration date
01/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/09/2024
Last transaction
03/08/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
IL
Examiner
KHAN, ASMAT A
Law office
M50
Current location
TMO LAW OFFICE 114
Mark description
The mark consists of the stylized word MEDISON with the letters MEDIS and N in black and the letter "O" resembling a red ball partially covered by a white slightly curved band going bottom left to top right diagonally across it with the white band expanding in size from bottom to top.
Holders and representatives
Holders
MEDISON BIOTECH (1995) LTD.
Representatives
Susan O. Goldsmith McCarter & English LLP
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalspharmaceutical preparations for the prevention and treatment of viral diseasesauto-immune and inflammatory diseasescardiovascular and pulmonary diseasescentral nervous system diseasesperipheral neurological system diseasespainallergiesanxietyinfectiondermatologic diseasesgastro-intestinal diseasesinfectious diseasesmetabolic diseasesoncologic diseasesophthalmic diseasesrespiratory diseasesdigital ulcerscerebrovascular diseases and medical preparations for the treatment of viral diseasesauto-immune and inflammatory diseasescardiovascular and pulmonary diseasescentral nervous system diseasesperipheral neurological system diseasespainallergiesanxietyinfectionsdermatologic diseasesgastro-intestinal diseasesinfectious diseasesmetabolic diseasesoncologic diseasesophthalmic diseasesrespiratory diseasesdigital ulcerscerebrovascular diseases; * none being generic or OTC pharmaceuticals or medical preparations; * vaccines; dietetic foods adapted for medical use
Class 35
Marketingsales promotion for third partiesdistribution of samplesdistribution of advertising materials all in the fields of pharmaceutical preparationsmedical preparationsveterinary preparationsdietetic food and substancesmedical and veterinary apparatus and equipmentwholesale and retail store services featuring pharmaceutical preparationsmedical preparationsveterinary preparationsdietetic food and substancesmedical and veterinary apparatus and equipment * ; none of aforementioned services being in the field of generic pharmaceuticals or OTC product *
Publications
History of USPTO decisions and trademark events.
46 publications found
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/09/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/29/2024
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
04/16/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/09/2024
FIMP
FINAL DISPOSITION PROCESSED
04/09/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/09/2024
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
03/11/2024
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
03/08/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/09/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
01/01/2024
GPNX
NOTIFICATION PROCESSED BY IB
10/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/24/2023
PUBO
PUBLISHED FOR OPPOSITION
10/24/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/18/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/18/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/18/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/27/2023
GNFR
FINAL REFUSAL E-MAILED
03/27/2023
CNFR
FINAL REFUSAL WRITTEN
03/27/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/15/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/07/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/19/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/19/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/24/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/06/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/03/2021
GNSL
LETTER OF SUSPENSION E-MAILED
11/03/2021
CNSL
SUSPENSION LETTER WRITTEN
11/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/29/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/29/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/29/2021
RFNT
REFUSAL PROCESSED BY IB
06/13/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/26/2021
RFRR
REFUSAL PROCESSED BY MPU
05/26/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/22/2021
CNRT
NON-FINAL ACTION WRITTEN
05/21/2021
MAFR
APPLICATION FILING RECEIPT MAILED
05/21/2021
DOCK
ASSIGNED TO EXAMINER
05/17/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/17/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/13/2021
Continuous trademark protection
Get notified about every new filing that threatens MEDISON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.